|Expense Ratio (net)||N/A|
|Last Cap Gain||N/A|
|Morningstar Risk Rating||N/A|
|Beta (3Y Monthly)||N/A|
|5y Average Return||N/A|
|Average for Category||N/A|
GENEVA and PRINCETON, N.J. and SAN DIEGO, Nov. 2, 2018 /PRNewswire/ -- Firmenich is pleased to announce the completion of its acquisition of Senomyx, Inc. ("Senomyx"), a global leader in taste innovation and expert in sweet, cooling and bitter solutions. Strengthening Firmenich's taste and nutrition capabilities, this acquisition adds to the Group's excellence in creating healthy and great tasting food, drink and oral care experiences for its customers. Sentry Merger Sub, Inc., a wholly owned subsidiary of Firmenich Incorporated ("Purchaser"), has successfully completed its tender offer to purchase all of the outstanding shares of common stock of Senomyx (SNMX), at a price of $1.50 per share, net to the seller in cash, without any interest thereon and less any applicable withholding taxes.
NEW YORK , Oct. 9, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Senomyx, Inc. ("SNMX" or the ...
NEW YORK, NY / ACCESSWIRE / October 8, 2018 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New ...
Do you own shares of Senomyx, Inc. (NASDAQ GM: SNMX)? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Senomyx, Inc. (“Senomyx” or the “Company”) (NASDAQ GM: SNMX) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Firmenich Incorporated (“Firmenich”).
GENEVA, Switzerland, PRINCETON, N.J. and SAN DIEGO, Oct. 4, 2018 /PRNewswire/ -- Firmenich Incorporated ("Firmenich") announced today that its wholly-owned U.S. subsidiary, Sentry Merger Sub, Inc. ("Sentry Merger Sub"), commenced the previously announced tender offer to acquire all of the outstanding common stock of Senomyx, Inc. ("Senomyx") (SNMX) for $1.50 per share, net to the seller in cash, without any interest thereon and less any applicable withholding taxes. The tender offer is scheduled to expire at 12:00 midnight, New York City time, on November 2, 2018 (one minute after 11:59 p.m., New York City time, on November 1, 2018), unless extended in accordance with the merger agreement and the applicable rules and regulations of the U.S. Securities and Exchange Commission ("SEC").
NEW YORK, NY / ACCESSWIRE / September 20, 2018 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in ...